A multicenter, open-label, randomized, proof-of-concept phase II clinical trial to assess the efficacy and safety of icatibant in patients infected with SARS-CoV-2 (COVID-19) and admitted to hospital units without invasive mechanical ventilation: study protocol (ICAT-COVID)
暂无分享，去创建一个
C. Tebé | M. Gasa | S. Videla | J. Sabater | X. Solanich | F. Llopis | X. Corbella | J. Jacob | J. Villoria | C. Gudiol | L. Calatayud | P. Hereu | A. Fernandez-Nistal | C. Montoto | A. Suárez-Lledó | A. Antolí | A. Rombauts | A. Otero | P. Malchair | R. Lleonart | A. Ferrer | Álvaro Zarauza | J. Giol | T. Carnaval | N. Pallarès | R. Rigo | H. Jofre | Ana Sánchez-Gabriel | Ramon Lleonart | Arnau Marta Tania Laura Xavier Anna Vanesa Mercè Carlota Antoli Benjumeda Bernal Calatayud Corbella | Marta Benjumeda | Tania Bernal | Vanesa Garcia | Leire Matellán | G. Rocamora | Freddy Rodríguez | J. C. Ruibal | Carmen Serrano | Ferran Llopis | C. Gudiol